KLP Kapitalforvaltning’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
IAM
KLP Kapitalforvaltning's AVBP Position: Q3 2026 in Review
KLP Kapitalforvaltning held its ArriVent BioPharma (AVBP) position steady in Q3 2026 at 8,200 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.
KLP Kapitalforvaltning first reported a position in AVBP in Q4 2024 and has held it in 8 quarters since. The position peaked at $285K in Q2 2026. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.
- KLP Kapitalforvaltning held 8,200 shares of ArriVent BioPharma worth $248K as of Q3 2026.
- KLP Kapitalforvaltning left its ArriVent BioPharma share count unchanged in Q3 2026.
- ArriVent BioPharma made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1780 holding.
- KLP Kapitalforvaltning first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 8 quarters since.
- KLP Kapitalforvaltning's ArriVent BioPharma position peaked at $285K in Q2 2026.
- 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.